首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Accurate hematopoietic stem cell frequency estimates by fitting multicell Poisson models substituting to the single-hit Poisson model in limiting dilution transplantation assays.
【24h】

Accurate hematopoietic stem cell frequency estimates by fitting multicell Poisson models substituting to the single-hit Poisson model in limiting dilution transplantation assays.

机译:通过在限制稀释移植测定法中替代多点Poisson模型拟合多细胞Poisson模型,可以准确估算造血干细胞的频率。

获取原文
获取原文并翻译 | 示例
           

摘要

Limiting dilution transplantation assay (LDTA) is considered as the gold standard method to assess hematopoietic stem cell (HSC) content. Traditionally, HSC frequency estimates are based on the single-hit Poisson model (SHPM), which posits that one donor HSC is sufficient to generate a progeny of detectable differentiated cells above a threshold value in hosts. However, there is no clear support for this statement, and it is receivable that more than one donor HSC may be necessary to provide detectable reconstitution in hosts above the threshold level for detection, usually 0.5% to 1% of donor-derived cells. To address this hypothesis, we evaluated the ability of a class of multiCell Poisson models (C(>/=1)PMs) to fit to LDTAs. In 7 of the 8 reanalyzed LDTAs, C(>/=1)PMs plausibly compete with the traditional SHPM. Model averaging across the set of plausible models gives 1.32- to 5.88-fold increases in HSC frequencies compared with the SHPM.
机译:极限稀释移植试验(LDTA)被认为是评估造血干细胞(HSC)含量的金标准方法。传统上,HSC频率估算基于一次命中的泊松模型(SHPM),该模型假定一个供体HSC足以在宿主体内产生高于阈值的可检测分化细胞后代。但是,对此说法没有明确的支持,可以接受的是,可能需要超过一个供体HSC才能在高于检测阈值水平的宿主中提供可检测的重组,通常为供体来源细胞的0.5%至1%。为了解决这个假设,我们评估了一类多细胞泊松模型(C(> / = 1)PMs)适应LDTA的能力。在重新分析的8个LDTA中的7个中,C(> / = 1)PM可能与传统SHPM竞争。与SHPM相比,将整个合理模型集中的模型平均得出的HSC频率增加了1.32到5.88倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号